#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alveolar rhabdomyosarcoma Antisynthetase syndrome Small for dates baby Neutropenia Metastases to central nervous system Hypoxic-ischaemic encephalopathy Ehlers-Danlos syndrome Cystic fibrosis Congenital ectodermal dysplasia Philadelphia positive acute lymphocytic leukaemia Systemic sclerosis pulmonary Adenomatous polyposis coli Langerhans cell sarcoma Vitamin B12 deficiency Renal cell carcinoma More trials…

    Learn about Rare Diseases

    Netherton’s syndrome – Treatment Burkitt’s lymphoma Glomerulonephritis membranous – Basic Information Leukoencephalopathy – Life with Disease Acquired haemophilia – Trials in Disease Medulloblastoma recurrent – Life with Disease Acute respiratory distress syndrome – Basic Information Myelodysplastic syndrome – Trials in Disease Mucopolysaccharidosis I Chondrosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ademetionine Padeliporfin Lenzumestrocel Interferon Alfa Vobramitamab Duocarmazine Sym025 Everolimus C1 Esterase Inhibitor (Human) Ly3298176 Ligelizumab Miglustat Imgn151 Pemigatinib Regorafenib Gebasaxturev Datopotamab Deruxtecan Neomycin Sulfate Quinapril Hydrochloride Acenocoumarol Aliskiren More therapies…

    Learn about Your Condition

    Laryngeal cancer Cervix carcinoma stage II Metastatic neoplasm Procedural hypotension Status epilepticus Congenital pseudarthrosis Familial mediterranean fever Inborn error of metabolism Renal transplant Breast cancer Follicular lymphoma Vulvar dysplasia Infantile apnoea Optic ischaemic neuropathy Albuminuria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Inflammation

  • Study of 18F-AlF-FAPI-74 PET/CT imaging compared to standard 18F-FDG PET/CT in patients with fever of unknown origin, IgG4-related disease, and axial spondyloarthritis

    Recruiting

    4 1 1
    Investigated Diseases:
    • Immunoglobulin G4 related disease
    • Pyrexia
    • Inflammation
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Belgium

  • Study on Stopping Prednisone for Patients with Inflammatory or Autoimmune Disorders

    Recruiting

    3 1 1
    Investigated Diseases:
    • Autoimmune disorder
    • Inflammation
    Investigated Drugs:
    • Prednisone
    Germany

  • Study on 68Gallium-FAPI PET/CT Imaging for Patients with Chronic Inflammatory Disorders Using Gallium (68Ga) Chloride and 68-FAPI-46

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Inflammation
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    • Gallium (68Ga) Chloride
    France

  • Testing acetylsalicylic acid and ketorolac to reduce complications after cancer surgery in patients with high inflammation levels

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Inflammation
    Investigated Drugs:
    • KETOROLAC TROMETAMOL
    • Acetylsalicylic Acid
    Italy

  • Study of Colchicine Treatment to Slow Down Aortic Valve Stenosis Progression in Adult Patients with Moderate Disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Aortic valve disease
    • Aortic valve stenosis
    • Inflammation
    Investigated Drugs:
    • Colchicine
    The Netherlands

  • A study to evaluate how JNJ-77242113 is absorbed by the body in healthy participants for the treatment of inflammatory diseases.

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Inflammation
    Belgium
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!